Search alternatives:
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
nn decrease » _ decrease (Expand Search), gy decreased (Expand Search), b1 decreased (Expand Search)
mg decrease » _ decrease (Expand Search), we decrease (Expand Search), gy decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
5581
-
5582
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
5583
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
5584
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
5585
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
5586
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
5587
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
5588
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
5589
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
5590
Trade-Off for Better Balanced Nonlinear Optical Performance with Disordered Si in ZnGeP<sub>2</sub>
Published 2022“…Theoretical calculations with special quasirandom structures show that the NLO coefficient decreases gradually with increasing Si content, but the decrease is tiny in the 0–50% range and acute in the 50–100% range of Si. …”
-
5591
-
5592
-
5593
Fig 4 -
Published 2023“…NETs in gastric tissues. Scale label 50 μm. NETs were observed in IgAV model group and decreased in DNase I intervention group but absent in control group. …”
-
5594
-
5595
-
5596
-
5597
De-identified dataset.
Published 2024“…</p><p>Results</p><p>The median age of the 37 participants at enrollment was 70.5 years; 30 (81%) had prior SARS-CoV-2 infection, and 76% received Pfizer-BioNTech and 24% Moderna homologous vaccines. …”
-
5598
-
5599
-
5600